PCMM
GSK icon

Private Capital Management (Minnesota)’s GSK GSK Stock Holding History

Private Capital Management (Minnesota)’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$264K Hold
5,200
– – 0.3% 138
2017
Q2 		$280K Sell
5,200
-960
-16% -$51.2K 0.31% 133
2017
Q1 		$325K Sell
6,160
-240
-4% -$12.2K 0.36% 123
2016
Q4 		$308K Buy
+6,400
New +$316K 0.34% 122

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Private Capital Management (Minnesota)'s GSK Position: Q3 2017 in Review

Private Capital Management (Minnesota) held its GSK (GSK) position steady in Q3 2017 at 5,200 shares worth $264K. The position accounts for 0.3% of the portfolio, ranked #138.

Private Capital Management (Minnesota) first reported a position in GSK in Q4 2016 and has held it in 4 quarters since. The position peaked at $325K in Q1 2017. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2017.

  • Private Capital Management (Minnesota) held 5,200 shares of GSK worth $264K as of Q3 2017.
  • Private Capital Management (Minnesota) left its GSK share count unchanged in Q3 2017.
  • GSK made up 0.3% of Private Capital Management (Minnesota)'s portfolio in Q3 2017, its #138 holding.
  • Private Capital Management (Minnesota) first reported a position in GSK in Q4 2016 and has held it in 4 quarters since.
  • Private Capital Management (Minnesota)'s GSK position peaked at $325K in Q1 2017.
  • 742 funds tracked by Wall St. Rank held GSK as of Q3 2017.

Based on Private Capital Management (Minnesota)'s 13F filing for Q3 2017, filed 26 Oct 2017.